Search Results - "Furness, G"
-
1
Phase-plate cryo-EM structure of a class B GPCR–G-protein complex
Published in Nature (London) (01-06-2017)“…Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, such as osteoporosis, diabetes and obesity. Here we report the…”
Get full text
Journal Article -
2
Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor–Gs complex
Published in Nature (London) (01-03-2018)“…The structure of the glucagon-like peptide 1 receptor (GLP-1R) with its biased agonist exendin-P5 sheds light on both receptor activation and the mechanism of…”
Get full text
Journal Article -
3
Structures of the human cholecystokinin 1 (CCK1) receptor bound to Gs and Gq mimetic proteins provide insight into mechanisms of G protein selectivity
Published in PLoS biology (01-06-2021)“…G protein-coupled receptors (GPCRs) are critical regulators of cellular function acting via heterotrimeric G proteins as their primary transducers with…”
Get full text
Journal Article -
4
Activation of the GLP-1 receptor by a non-peptidic agonist
Published in Nature (London) (16-01-2020)“…Class B G-protein-coupled receptors are major targets for the treatment of chronic diseases, including diabetes and obesity 1 . Structures of active receptors…”
Get full text
Journal Article -
5
Structure and dynamics of the active Gs-coupled human secretin receptor
Published in Nature communications (18-08-2020)“…The class B secretin GPCR (SecR) has broad physiological effects, with target potential for treatment of metabolic and cardiovascular disease. Molecular…”
Get full text
Journal Article -
6
Cholesterol-dependent dynamic changes in the conformation of the type 1 cholecystokinin receptor affect ligand binding and G protein coupling
Published in PLoS biology (31-07-2024)“…Development of optimal therapeutics for disease states that can be associated with increased membrane cholesterol requires better molecular understanding of…”
Get full text
Journal Article -
7
Prolonged calcitonin receptor signaling by salmon, but not human calcitonin, reveals ligand bias
Published in PloS one (18-03-2014)“…Salmon calcitonin (sCT) and human calcitonin (hCT) are pharmacologically distinct. However, the reason for the differences is unclear. Here we analyze the…”
Get full text
Journal Article -
8
Structure and Dynamics of Adrenomedullin Receptors AM1 and AM2 Reveal Key Mechanisms in the Control of Receptor Phenotype by Receptor Activity-Modifying Proteins
Published in ACS pharmacology & translational science (10-04-2020)“…Adrenomedullin (AM) and calcitonin gene-related peptide (CGRP) receptors are critically important for metabolism, vascular tone, and inflammatory response. AM…”
Get full text
Journal Article -
9
Expression and activity of the calcitonin receptor family in a sample of primary human high-grade gliomas
Published in BMC cancer (18-02-2019)“…Glioblastoma (GBM) is the most common and aggressive type of primary brain cancer. With median survival of less than 15 months, identification and validation…”
Get full text
Journal Article -
10
Dominant Negative G Proteins Enhance Formation and Purification of Agonist-GPCR‑G Protein Complexes for Structure Determination
Published in ACS pharmacology & translational science (14-09-2018)“…Advances in structural biology have yielded exponential growth in G protein-coupled receptor (GPCR) structure solution. Nonetheless, the instability of fully…”
Get full text
Journal Article -
11
Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics
Published in British journal of pharmacology (01-01-2015)“…Background and Purpose Clinical use of cinacalcet in hyperparathyroidism is complicated by its tendency to induce hypocalcaemia, arising partly from activation…”
Get full text
Journal Article -
12
Receptor Activity-Modifying Proteins Differentially Modulate the G Protein-Coupling Efficiency of Amylin Receptors
Published in Endocrinology (Philadelphia) (01-11-2008)“…Receptor activity-modifying proteins (RAMPs) 1, 2, and 3 are prototypic G protein-coupled receptor accessory proteins that can alter not only receptor…”
Get full text
Journal Article -
13
Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery
Published in Proceedings of the National Academy of Sciences - PNAS (06-11-2012)“…The glucagon-like peptide-1 receptor (GLP-1R) is a family B G protein-coupled receptor and an important drug target for the treatment of type II diabetes, with…”
Get full text
Journal Article -
14
Dopamine and ghrelin receptor co‐expression and interaction in the spinal defecation centers
Published in Neurogastroenterology and motility (01-05-2021)“…Background Dopamine receptor 2 (DRD2) and ghrelin receptor (GHSR1a) agonists both stimulate defecation by actions at the lumbosacral defecation center…”
Get full text
Journal Article -
15
Dianthin-30 or gelonin versus monomethyl auristatin E, each configured with an anti-calcitonin receptor antibody, are differentially potent in vitro in high-grade glioma cell lines derived from glioblastoma
Published in Cancer Immunology, Immunotherapy (01-09-2017)“…We have reported that calcitonin receptor (CTR) is widely expressed in biopsies from the lethal brain tumour glioblastoma by malignant glioma and brain…”
Get full text
Journal Article -
16
TrkB Agonist LM22A-4 Increases Oligodendroglial Populations During Myelin Repair in the Corpus Callosum
Published in Frontiers in molecular neuroscience (27-08-2019)“…The neurotrophin, brain-derived neurotrophic factor (BDNF) promotes central nervous system (CNS) myelination during development and after injury. This is…”
Get full text
Journal Article -
17
The Molecular Control of Calcitonin Receptor Signaling
Published in ACS pharmacology & translational science (08-02-2019)“…The calcitonin receptor (CTR) is a class B G protein-coupled receptor (GPCR) that responds to the peptide hormone calcitonin (CT). CTs are clinically approved…”
Get full text
Journal Article -
18
Antibiotic or induction agent? Another problem from a possible solution
Published in Anaesthesia (01-09-2012)Get full text
Journal Article -
19
Building the case for the calcitonin receptor as a viable target for the treatment of glioblastoma
Published in Therapeutic Advances in Medical Oncology (2020)“…Researchers are actively seeking novel targeted therapies for the brain tumour glioblastoma (GBM) as the mean survival is less than 15 months. Here we discuss…”
Get full text
Book Review Journal Article -
20
Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol
Published in Frontiers in endocrinology (Lausanne) (07-12-2021)“…Drugs useful in prevention/treatment of obesity could improve health. Cholecystokinin (CCK) is a key regulator of appetite, working through the type 1 CCK…”
Get full text
Journal Article